Clinical
RSSArticles
-
Long-Term Statin Use Associated with Lower Stroke Risk
A cohort of Danish patients who were taking the cholesterol control medication were less likely to experience an intracerebral hemorrhage.
-
A Review of Insulin Transition
Diabetes mellitus is a collection of chronic metabolic diseases that occur either as the result of insulin deficiency or insulin resistance. One of the primary goals in diabetes treatment includes lowering blood glucose levels sufficiently to prevent microvascular and macrovascular complications. The type of insulin prescribed depends on multiple factors, and insulins frequently are interchanged. Before choosing or transitioning to an appropriate insulin, consider all social determinants and individualize the treatment regimen as “one size does not fit all.”
-
More Research Needed on Link Between Hormonal Contraceptives and Stress
Reproductive health clinicians and their patients need more information about how hormonal contraceptives may affect people’s mood changes and depression, according to the authors of a recent paper.
-
Legality and Chilling Effect of Abortion Care in Dobbs Era
In this Q&A about how state abortion bans are affecting women with both planned and unplanned pregnancies, Contraceptive Technology Update addresses some of the legal issues raised by state laws and bans.
-
When Lawmakers Make Medical Decisions, Patients and Providers Suffer
Recent suggests a future in which doctors in abortion-ban states will have to ask how much of a threat of death is needed before they can give patients the care needed to prevent their death or serious morbidity.
-
Too Many Physicians Lack Accurate Information About Contraception
New research revealed that a significant number of physicians hold erroneous beliefs about how contraceptives work. Many believe emergency contraception causes abortions, and some doctors believe IUDs and other forms of birth control also work as abortifacients, according to a study of Wisconsin physicians’ beliefs about contraception.
-
Reproductive Health Workforce May Look Different in 10 Years
The reproductive health workforce has changed considerably in the past few years. It is possible it will continue to evolve over the next decade. COVID-19 placed an incredible strain on the workforce, and it is facing a second huge strain because of the U.S. Supreme Court’s decision to overturn Roe v. Wade.
-
What Will Happen to the Reproductive Healthcare Workforce?
Months after Roe v. Wade was overturned, reproductive healthcare providers and patients are experiencing enormous — and sometimes disastrous — changes. For instance, state abortion bans are expected to affect where OB/GYNs and other reproductive health clinicians choose to study and practice. These bans also will affect how and whether medical students and residents are fully educated in contraceptive care and counseling, abortion care, miscarriage care, ectopic pregnancy treatment, and high-risk pregnancy care.
-
Current and Future Options for Male Contraception
Following the landmark Dobbs v. Jackson Women’s Health Organization decision that ended the constitutional right to abortion in the United States, the importance of contraception has grown. This article summarizes the existing male contraceptive options and reviews the status of future ones.
-
Ibrexafungerp for Vulvovaginal Candidiasis
A randomized clinical trial compared one day of oral ibrexafungerp with placebo for female patients with vulvovaginal candidiasis (VVC). It found ibrexafungerp to be safe and effective, with mild diarrhea the most common adverse event. Ibrexafungerp differs mechanistically from azoles and appears to be a promising new treatment for VVC.